Clinical Trial Update: Phase 3 Multicenter Randomized Double Blind Placebo Controlled Study With Antibacterial Prophylaxis in Azacitidine Treated MDS Patients [Phase 3]

View source ↗

Summary

Phase 3 multicenter randomized trial assessing antibacterial prophylaxis in azacitidine-treated myelodysplastic syndrome patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Snippet

Sponsor: Sheba Medical Center | Conditions: Prevention | Phase 3 | Status: COMPLETED